{"count": 17, "results": [{"_id": "37225730", "pmid": 37225730, "pmcid": "PMC10209144", "title": "Association between visceral obesity, metformin use, and recurrence risk in early-stage colorectal cancer", "journal": "Sci Rep", "authors": ["Vedire YR", "Mukherjee S", "Dondapati S", "Yendamuri S"], "date": "2023-05-24T00:00:00Z", "doi": "10.1038/s41598-023-34690-y", "meta_date_publication": "2023 May 24", "meta_volume": "13", "meta_issue": "1", "meta_pages": "8401", "score": 50268.06, "text_hl": "Association between @<m>DISEASE_Obesity_Abdominal</m> @DISEASE_MESH:D056128 @@@visceral obesity@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use, and recurrence risk in early-stage @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@colorectal cancer@@@", "citations": {"NLM": "Vedire YR, Mukherjee S, Dondapati S, Yendamuri S. Association between visceral obesity, metformin use, and recurrence risk in early-stage colorectal cancer Sci Rep. 2023 May 24;13(1):8401. PMID: 37225730", "BibTeX": "@article{37225730, title={Association between visceral obesity, metformin use, and recurrence risk in early-stage colorectal cancer}, author={Vedire YR and Mukherjee S and Dondapati S and Yendamuri S}, journal={Sci Rep}, volume={13}, number={1}, pages={8401}}"}}, {"_id": "40843067", "pmid": 40843067, "title": "Combined metformin and exenatide versus only metformin treatments in polycystic ovary syndrome with abdominal obesity and network pharmacology of gene expression: evidence from a randomized clinical trial.", "journal": "Ther Adv Endocrinol Metab", "authors": ["Xuesong D", "Tao T", "Weilu W", "Wei X", "Wei X", "Yan D", "Yanfang W", "Ruilin M", "Yingying G", "Yue W", "Pérez-López FR", "Yang W"], "date": "2025-08-19T00:00:00Z", "doi": "10.1177/20420188251355411", "meta_date_publication": "2025", "meta_volume": "16", "meta_issue": "", "meta_pages": "20420188251355411", "score": 50266.81, "text_hl": "Combined @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Exenatide @CHEMICAL_MESH:D000077270 @@@exenatide@@@ versus only @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatments in @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@ with @<m>DISEASE_Obesity_Abdominal</m> @DISEASE_MESH:D056128 @@@abdominal obesity@@@ and network pharmacology of gene expression: evidence from a randomized clinical trial.", "citations": {"NLM": "Xuesong D, Tao T, Weilu W, Wei X, Wei X, Yan D, Yanfang W, Ruilin M, Yingying G, Yue W, Pérez-López FR, Yang W. Combined metformin and exenatide versus only metformin treatments in polycystic ovary syndrome with abdominal obesity and network pharmacology of gene expression: evidence from a randomized clinical trial. Ther Adv Endocrinol Metab. 2025;16():20420188251355411. PMID: 40843067", "BibTeX": "@article{40843067, title={Combined metformin and exenatide versus only metformin treatments in polycystic ovary syndrome with abdominal obesity and network pharmacology of gene expression: evidence from a randomized clinical trial.}, author={Xuesong D and Tao T and Weilu W and Wei X and Wei X and Yan D and Yanfang W and Ruilin M and Yingying G and Yue W and Pérez-López FR and Yang W}, journal={Ther Adv Endocrinol Metab}, volume={16}, pages={20420188251355411}}"}}, {"_id": "36395633", "pmid": 36395633, "title": "Metformin delivery via iontophoresis based on kappa-carrageenan cryogels.", "journal": "Int J Biol Macromol", "authors": ["Saramas T", "Sakunpongpitiporn P", "Rotjanasuworapong K", "Morarad R", "Niamlang S", "Sirivat A"], "date": "2022-12-31T00:00:00Z", "doi": "10.1016/j.ijbiomac.2022.11.098", "meta_date_publication": "2022 Dec 31", "meta_volume": "223", "meta_issue": "Pt A", "meta_pages": "702-712", "score": 50255.812, "text_hl": "The @CHEMICAL_Carrageenan @CHEMICAL_MESH:D002351 @@@kappaC@@@ 0.8 % v/v matrix at the applied electric strength of +6.0 V has been shown here to be potential to be used as the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ transdermal controlled delivery patch for @<m>DISEASE_Obesity_Abdominal</m> @DISEASE_MESH:D056128 @@@abdominal obesity@@@ and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@.", "citations": {"NLM": "Saramas T, Sakunpongpitiporn P, Rotjanasuworapong K, Morarad R, Niamlang S, Sirivat A. Metformin delivery via iontophoresis based on kappa-carrageenan cryogels. Int J Biol Macromol. 2022 Dec 31;223(Pt A):702-712. PMID: 36395633", "BibTeX": "@article{36395633, title={Metformin delivery via iontophoresis based on kappa-carrageenan cryogels.}, author={Saramas T and Sakunpongpitiporn P and Rotjanasuworapong K and Morarad R and Niamlang S and Sirivat A}, journal={Int J Biol Macromol}, volume={223}, number={Pt A}, pages={702-712}}"}}, {"_id": "25306749", "pmid": 25306749, "title": "[Efficacy of metformin in abdominal obesity].", "journal": "Ter Arkh", "authors": ["Mkrtumian AM", "Markova TN", "Kichigin VA", "Podachina SV", "Zhuchkova SM"], "date": "2014-01-01T00:00:00Z", "meta_date_publication": "2014", "meta_volume": "86", "meta_issue": "8", "meta_pages": "80-4", "score": 50091.46, "text_hl": "[Efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Obesity_Abdominal</m> @DISEASE_MESH:D056128 @@@abdominal obesity@@@].", "citations": {"NLM": "Mkrtumian AM, Markova TN, Kichigin VA, Podachina SV, Zhuchkova SM. [Efficacy of metformin in abdominal obesity]. Ter Arkh. 2014;86(8):80-4. PMID: 25306749", "BibTeX": "@article{25306749, title={[Efficacy of metformin in abdominal obesity].}, author={Mkrtumian AM and Markova TN and Kichigin VA and Podachina SV and Zhuchkova SM}, journal={Ter Arkh}, volume={86}, number={8}, pages={80-4}}"}}, {"_id": "10195381", "pmid": 10195381, "title": "Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity.", "journal": "J Endocrinol Invest", "authors": ["Oleandri SE", "Maccario M", "Rossetto R", "Procopio M", "Grottoli S", "Avogadri E", "Gauna C", "Ganzaroli C", "Ghigo E"], "date": "1999-02-01T00:00:00Z", "doi": "10.1007/BF03350893", "meta_date_publication": "1999 Feb", "meta_volume": "22", "meta_issue": "2", "meta_pages": "134-40", "score": 50062.777, "text_hl": "Three-month treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or @CHEMICAL_Dexfenfluramine @CHEMICAL_MESH:D020372 @@@dexfenfluramine@@@ does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in @<m>DISEASE_Obesity_Abdominal</m> @DISEASE_MESH:D056128 @@@abdominal obesity@@@.", "citations": {"NLM": "Oleandri SE, Maccario M, Rossetto R, Procopio M, Grottoli S, Avogadri E, Gauna C, Ganzaroli C, Ghigo E. Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity. J Endocrinol Invest. 1999 Feb;22(2):134-40. PMID: 10195381", "BibTeX": "@article{10195381, title={Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity.}, author={Oleandri SE and Maccario M and Rossetto R and Procopio M and Grottoli S and Avogadri E and Gauna C and Ganzaroli C and Ghigo E}, journal={J Endocrinol Invest}, volume={22}, number={2}, pages={134-40}}"}}, {"_id": "14502101", "pmid": 14502101, "title": "Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes.", "journal": "Diabetes Metab", "authors": ["Després JP"], "date": "2003-09-01T00:00:00Z", "doi": "10.1016/s1262-3636(03)72788-8", "meta_date_publication": "2003 Sep", "meta_volume": "29", "meta_issue": "4 Pt 2", "meta_pages": "6S53-61", "score": 50054.016, "text_hl": "Potential contribution of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to the management of @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular disease@@@ risk in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Obesity_Abdominal</m> @DISEASE_MESH:D056128 @@@abdominal obesity@@@, the @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@ and @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@.", "citations": {"NLM": "Després JP. Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes. Diabetes Metab. 2003 Sep;29(4 Pt 2):6S53-61. PMID: 14502101", "BibTeX": "@article{14502101, title={Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes.}, author={Després JP}, journal={Diabetes Metab}, volume={29}, number={4 Pt 2}, pages={6S53-61}}"}}, {"_id": "20873243", "pmid": 20873243, "title": "[Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].", "journal": "Ter Arkh", "authors": ["Onuchin SG", "Elsukova OS", "Solov'ev OV", "Onuchina EL"], "date": "2010-01-01T00:00:00Z", "meta_date_publication": "2010", "meta_volume": "82", "meta_issue": "8", "meta_pages": "34-41", "score": 50053.266, "text_hl": "SUBJECTS AND METHODS: One hundred and eighty-two @SPECIES_9606 @@@women@@@ who were over 55 years of age with a more than 3-5-year history of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@ and more than one-year decompensation, @<m>DISEASE_Obesity_Abdominal</m> @DISEASE_MESH:D056128 @@@abdominal obesity@@@ (@<m>DISEASE_Obesity_Abdominal</m> @DISEASE_MESH:D056128 @@@AO@@@), arterial @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, and concomitant treatment-matched were randomized into 4 groups: (1) @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (n=46); (2) a combination of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and gliclaside MB (n=47); (3) @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @GENE_INS @GENE_3630 @@@insulin@@@ (n=44); and (4) @GENE_INS @GENE_3630 @@@insulin@@@ (n=45). ", "citations": {"NLM": "Onuchin SG, Elsukova OS, Solov'ev OV, Onuchina EL. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus]. Ter Arkh. 2010;82(8):34-41. PMID: 20873243", "BibTeX": "@article{20873243, title={[Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].}, author={Onuchin SG and Elsukova OS and Solov'ev OV and Onuchina EL}, journal={Ter Arkh}, volume={82}, number={8}, pages={34-41}}"}}, {"_id": "23951921", "pmid": 23951921, "title": "[Clinical effectiveness of metformin and ramipril combination in complex therapy of patients with metabolic syndrome].", "journal": "Lik Sprava", "authors": ["Savchenko LH", "Kaĭdasheva EI", "Kutsenko LO", "Kutsenko NL", "Hordyns'ka IL", "Mamontova TV", "Markina TM", "Kaĭdashev IP"], "date": "2013-01-01T00:00:00Z", "meta_date_publication": "2013 Jan-Feb", "meta_volume": "", "meta_issue": "1", "meta_pages": "109-17", "score": 50052.125, "text_hl": "[Clinical effectiveness of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@ combination in complex therapy of @SPECIES_9606 @@@patients@@@ with @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@].", "citations": {"NLM": "Savchenko LH, Kaĭdasheva EI, Kutsenko LO, Kutsenko NL, Hordyns'ka IL, Mamontova TV, Markina TM, Kaĭdashev IP. [Clinical effectiveness of metformin and ramipril combination in complex therapy of patients with metabolic syndrome]. Lik Sprava. 2013 Jan-Feb;(1):109-17. PMID: 23951921", "BibTeX": "@article{23951921, title={[Clinical effectiveness of metformin and ramipril combination in complex therapy of patients with metabolic syndrome].}, author={Savchenko LH and Kaĭdasheva EI and Kutsenko LO and Kutsenko NL and Hordyns'ka IL and Mamontova TV and Markina TM and Kaĭdashev IP}, journal={Lik Sprava}, number={1}, pages={109-17}}"}}, {"_id": "20831045", "pmid": 20831045, "title": "[Dynamics of structural-functional parameters of cardiovascular system during use of complex therapy of women with type 2 diabetes mellitus].", "journal": "Kardiologiia", "authors": ["Onuchin SG", "Elsukova OS", "Solov'ev OV", "Onuchina EL"], "date": "2010-01-01T00:00:00Z", "meta_date_publication": "2010", "meta_volume": "50", "meta_issue": "5", "meta_pages": "29-35", "score": 50052.004, "text_hl": "Long-term use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in complex multifactorial therapy of @SPECIES_9606 @@@women@@@ with decompensated @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes DM@@@, @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@AH@@@ and @<m>DISEASE_Obesity_Abdominal</m> @DISEASE_MESH:D056128 @@@abdominal obesity@@@ provides improvement of @CHEMICAL_Carbohydrates @CHEMICAL_MESH:D002241 @@@carbohydrate@@@ and @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ metabolism, lowering of arterial pressure, diminishment of @DISEASE_Albuminuria @DISEASE_MESH:D000419 @@@albuminuria@@@, @DISEASE_Ventricular_Dysfunction_Left @DISEASE_MESH:D018487 @@@diastolic dysfunction@@@, and @DISEASE_Isolated_Noncompaction_of_the_Ventricular_Myocardium @DISEASE_MESH:D056830 @@@stiffness of left ventricular myocardium@@@. ", "citations": {"NLM": "Onuchin SG, Elsukova OS, Solov'ev OV, Onuchina EL. [Dynamics of structural-functional parameters of cardiovascular system during use of complex therapy of women with type 2 diabetes mellitus]. Kardiologiia. 2010;50(5):29-35. PMID: 20831045", "BibTeX": "@article{20831045, title={[Dynamics of structural-functional parameters of cardiovascular system during use of complex therapy of women with type 2 diabetes mellitus].}, author={Onuchin SG and Elsukova OS and Solov'ev OV and Onuchina EL}, journal={Kardiologiia}, volume={50}, number={5}, pages={29-35}}"}}, {"_id": "22525206", "pmid": 22525206, "title": "Metformin-based treatment for obesity-related hypertension:  a randomized, double-blind, placebo-controlled trial.", "journal": "J Hypertens", "authors": ["He H", "Zhao Z", "Chen J", "Ni Y", "Zhong J", "Yan Z", "Li Y", "Liu D", "Pletcher MJ", "Zhu Z"], "date": "2012-07-01T00:00:00Z", "doi": "10.1097/HJH.0b013e328353e249", "meta_date_publication": "2012 Jul", "meta_volume": "30", "meta_issue": "7", "meta_pages": "1430-9", "score": 50045.49, "text_hl": "There was no significant difference in adverse events (P = 0.785). CONCLUSIONS: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has no effect on blood pressure and @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@ levels, but it does reduce total @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@, @<m>DISEASE_Obesity_Abdominal</m> @DISEASE_MESH:D056128 @@@abdominal obesity@@@ and @GENE_CRP @GENE_1401 @@@C-reactive protein@@@ levels in @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ without @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@.", "citations": {"NLM": "He H, Zhao Z, Chen J, Ni Y, Zhong J, Yan Z, Li Y, Liu D, Pletcher MJ, Zhu Z. Metformin-based treatment for obesity-related hypertension:  a randomized, double-blind, placebo-controlled trial. J Hypertens. 2012 Jul;30(7):1430-9. PMID: 22525206", "BibTeX": "@article{22525206, title={Metformin-based treatment for obesity-related hypertension:  a randomized, double-blind, placebo-controlled trial.}, author={He H and Zhao Z and Chen J and Ni Y and Zhong J and Yan Z and Li Y and Liu D and Pletcher MJ and Zhu Z}, journal={J Hypertens}, volume={30}, number={7}, pages={1430-9}}"}}]}